Novel Substituted Pyrazoles as 5‑HT1A Agonists for Treating Neuropsychiatric Diseases

  • ACS Med Chem Lett. 2025 Jun 3;16(6):978-979. doi: 10.1021/acsmedchemlett.5c00306.
Ram W Sabnis  1
Affiliations
  • 1. Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Atlanta, Georgia 30309, United States.
PMID: 40529086 DOI: 10.1021/acsmedchemlett.5c00306
Abstract

Provided herein are novel substituted pyrazoles as 5-HT1A agonists, pharmaceutical compositions, use of such compounds in treating neuropsychiatric diseases, and processes for preparing such compounds.

Products